Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rangering i aksjer #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aksjekurs
$36.75
Sist synkronisert: 2026-08-27
Markedsverdi
$1.63B
Endring (1 dag)
-0.78%
Endring (1 år)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Historikk for aksjesplitt for Avalyn Pharma Inc. Common Stock (AVLN)
Aksjen Avalyn Pharma Inc. Common Stock (symbol: AVLN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 28, 2026.
Én AVLN-aksje kjøpt før Aug 28, 2026 tilsvarer i dag 0 AVLN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH